Register
Medicines reference
Product

DIXIE Permethrin

Permethrin · Quimica de Munguia S.A. (Quimunsa)

2 forms: spot-on. In force in Georgia: 2 of 2 (veterinary register).

Do not use on cats. Prevent cats from contacting or grooming a treated dog; follow the exact label for the separation period. Species safety: cats →

Forms and doses2 of 2 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Enter weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
Spot-on · Dog up to 14.99 kg Dog up to 14.99 kg 1 pipette
Apply to intact skin: one 1 ml pipette below 15 kg, or two 1 ml pipettes at 15-30 kg. Flea and tick protection lasts up to 4 weeks; mosquito and sandfly durations are label-specific. NEVER USE IN CATS: permethrin is extremely toxic and may be fatal. Keep treated dogs away from cats for 72 hours and until the application site is dry; if a cat is exposed, wash it with shampoo or soap and seek a veterinarian immediately. Do not use under 2 weeks or on extensive skin lesions. In dogs below 2 kg, use only after veterinary benefit-risk assessment. Avoid eyes, mouth and licking. Do not combine with other pyrethroid, organophosphate or carbamate insecticides. Keep out of waterways; do not let treated dogs swim in surface water for 2 days.
· single application; repeat only on veterinary advice, no sooner than 7 days
single application; repeat only on veterinary advice, no sooner than 7 days Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: დიქსი პერმეტრინი 715 მგ დასაწვეთებელი ხსნარი ძაღლებისთვის
№ 156-11
Verified on: 20 Oct 2026
Spot-on · Dog 14.99–30 kg Dog 14.99–30 kg 2 pipettes
Apply to intact skin: one 1 ml pipette below 15 kg, or two 1 ml pipettes at 15-30 kg. Flea and tick protection lasts up to 4 weeks; mosquito and sandfly durations are label-specific. NEVER USE IN CATS: permethrin is extremely toxic and may be fatal. Keep treated dogs away from cats for 72 hours and until the application site is dry; if a cat is exposed, wash it with shampoo or soap and seek a veterinarian immediately. Do not use under 2 weeks or on extensive skin lesions. In dogs below 2 kg, use only after veterinary benefit-risk assessment. Avoid eyes, mouth and licking. Do not combine with other pyrethroid, organophosphate or carbamate insecticides. Keep out of waterways; do not let treated dogs swim in surface water for 2 days.
· single application; repeat only on veterinary advice, no sooner than 7 days
single application; repeat only on veterinary advice, no sooner than 7 days Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: დიქსი პერმეტრინი 715 მგ დასაწვეთებელი ხსნარი ძაღლებისთვის
№ 156-11
Verified on: 20 Oct 2026
Details: pack, label wording, sources, registration

DIXIE Permethrin, Spot-on

Permethrin 715 mg/1 ml spot-on solution for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.8/10
Very good
vetman assessment

DIXIE Permethrin

Permethrin 715 mg/1 ml spot-on solution for dogs
Assessed clinical scopeDog · Full dog label: treatment and prevention of Ctenocephalides flea and Rhipicephalus tick infestations, plus labelled mosquito insecticidal and sand-fly repellent activity, with the 715 mg permethrin pipette · On the skin
Care settingHome topical ectoparasite treatment after exact weighing and assessment of cats, waterways and other exposure risks in the household
vetman score 7.8/10 Very good
Evidence confidence: Medium Georgia: Yes, veterinary · № 156-11 · Verified on 20 Oct 2026

A credible four-week canine permethrin spot-on with additional but shorter vector activity. It is useful only where strict cat-exposure prevention and environmental precautions are realistic; the 1 ml format is less convenient for 15-30 kg dogs.

Regulatory and scientific credibility9.0/10

The exact 715 mg/1 ml presentation is actively registered in Georgia and has a current detailed AEMPS SPC; independent literature supports canine permethrin, while exact-product comparative trials are limited.

Clinical efficacy7.8/10

The label supports four weeks against fleas and ticks, three weeks of mosquito insecticidal activity and one week of sand-fly repellency. Class evidence is credible, but protection duration varies by vector and occasional attachment or biting means transmission cannot be excluded.

Safety and tolerability6.8/10

Canine adverse events are very rare but include local, gastrointestinal, behavioural and neurologic effects. Cat exposure can be fatal; strict 72-hour separation, handler precautions, insecticide exclusions and aquatic protection materially constrain safe use.

Clinical practicality7.5/10

A fixed pipette is convenient below 15 kg, but dogs from 15-30 kg require two pipettes at two sites. Exact weighing, 72-hour cat separation, drying, child-contact and swimming restrictions add substantial household workflow.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats. Keep treated dogs away from cats for 72 hours and until dry; wash an exposed cat with shampoo or soap and seek veterinary care immediately.
  • Do not use below 2 weeks of age, on extensive skin lesions or with hypersensitivity to permethrin or excipients.
  • Below 2 kg use only after veterinary benefit-risk assessment; consult before use in sick or debilitated dogs.
  • Do not combine with other pyrethroid, organophosphate or carbamate insecticides.
  • Avoid skin, eye and mouth exposure; keep children from handling the dog until dry and do not share a bed immediately after treatment.
  • Permethrin is hazardous to aquatic organisms; keep treated dogs out of surface water for two days.
  • Monitor lethargy, local skin reaction, salivation, vomiting, diarrhoea, agitation, ataxia, tremor, seizure or paresis; bathe and seek care if significant signs occur.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Permethrin715 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer (register)
QUIMICA DE MUNGUÍA. S.A. (QUIMUNSA), Spain
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1763, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: დიქსი პერმეტრინი 715 მგ დასაწვეთებელი ხსნარი ძაღლებისთვის
№ 156-11
Verified on: 20 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
1 pipette
Apply to intact skin: one 1 ml pipette below 15 kg, or two 1 ml pipettes at 15-30 kg. Flea and tick protection lasts up to 4 weeks; mosquito and sandfly durations are label-specific. NEVER USE IN CATS: permethrin is extremely toxic and may be fatal. Keep treated dogs away from cats for 72 hours and until the application site is dry; if a cat is exposed, wash it with shampoo or soap and seek a veterinarian immediately. Do not use under 2 weeks or on extensive skin lesions. In dogs below 2 kg, use only after veterinary benefit-risk assessment. Avoid eyes, mouth and licking. Do not combine with other pyrethroid, organophosphate or carbamate insecticides. Keep out of waterways; do not let treated dogs swim in surface water for 2 days.
Dog up to 14.99 kg On the skin single application; repeat only on veterinary advice, no sooner than 7 days
AEMPS SPC 2025
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
DIXIE Permethrin 715 mg spot-on solution for dogs - Summary of Product Characteristics
Spanish Agency of Medicines and Medical Devices, CIMA-Vet, 2025
2 pipettes
Apply to intact skin: one 1 ml pipette below 15 kg, or two 1 ml pipettes at 15-30 kg. Flea and tick protection lasts up to 4 weeks; mosquito and sandfly durations are label-specific. NEVER USE IN CATS: permethrin is extremely toxic and may be fatal. Keep treated dogs away from cats for 72 hours and until the application site is dry; if a cat is exposed, wash it with shampoo or soap and seek a veterinarian immediately. Do not use under 2 weeks or on extensive skin lesions. In dogs below 2 kg, use only after veterinary benefit-risk assessment. Avoid eyes, mouth and licking. Do not combine with other pyrethroid, organophosphate or carbamate insecticides. Keep out of waterways; do not let treated dogs swim in surface water for 2 days.
Dog 14.99–30 kg On the skin single application; repeat only on veterinary advice, no sooner than 7 days
AEMPS SPC 2025
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
DIXIE Permethrin 715 mg spot-on solution for dogs - Summary of Product Characteristics
Spanish Agency of Medicines and Medical Devices, CIMA-Vet, 2025
Spot-on · Dog 14.99–30 kg Dog 14.99–30 kg 1 pipette
Apply one complete 2 ml pipette to intact skin, divided equally between two sites from the shoulder blades to the tail base, for a dog weighing 15-30 kg. Flea and tick protection lasts up to 4 weeks; mosquito and sandfly durations are label-specific. NEVER USE IN CATS: permethrin is extremely toxic and may be fatal. Keep treated dogs away from cats for 72 hours and until dry; after cat exposure, wash with shampoo or soap and seek a veterinarian immediately. Do not use under 2 weeks or on extensive skin lesions. Avoid eyes, mouth and licking. Do not combine with other pyrethroid, organophosphate or carbamate insecticides. Keep out of waterways; do not let treated dogs swim in surface water for 2 days.
· single application; repeat only on veterinary advice, no sooner than 7 days
single application; repeat only on veterinary advice, no sooner than 7 days Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: დიქსი პერმეტრინი 1430 მგ დასაწვეთებელი ხსნარი ძაღლებისთვის
№ 138-11
Verified on: 20 Oct 2026
Details: pack, label wording, sources, registration

DIXIE Permethrin, Spot-on

Permethrin 1430 mg/2 ml spot-on solution for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.9/10
Very good
vetman assessment

DIXIE Permethrin

Permethrin 1430 mg/2 ml spot-on solution for dogs
Assessed clinical scopeDog · Full dog label: treatment and prevention of Ctenocephalides flea and Rhipicephalus tick infestations, plus labelled mosquito insecticidal and sand-fly repellent activity, in 15-30 kg dogs with one 1430 mg permethrin pipette · On the skin
Care settingHome topical ectoparasite treatment after exact weighing and assessment of cats, waterways and other exposure risks in the household
vetman score 7.9/10 Very good
Evidence confidence: Medium Georgia: Yes, veterinary · № 138-11 · Verified on 20 Oct 2026

A credible weight-specific canine permethrin spot-on with four-week flea/tick activity and shorter vector effects. The single 2 ml pipette is practical, but fatal feline toxicity and household/environmental precautions remain decisive limitations.

Regulatory and scientific credibility9.0/10

The exact 1430 mg/2 ml, 15-30 kg presentation is actively registered in Georgia and has a current detailed AEMPS SPC; independent literature supports canine permethrin, while exact-product comparative trials are limited.

Clinical efficacy7.8/10

The label supports four weeks against fleas and ticks, three weeks of mosquito insecticidal activity and one week of sand-fly repellency. Class evidence is credible, but duration varies by vector and pathogen transmission cannot be excluded.

Safety and tolerability6.8/10

Canine adverse events are very rare but include local, gastrointestinal, behavioural and neurologic effects. Cat exposure can be fatal; strict 72-hour separation, handler precautions, insecticide exclusions and aquatic protection materially constrain safe use.

Clinical practicality8.0/10

One weight-matched pipette divided between two sites is more convenient than two small pipettes for a 15-30 kg dog. Exact weighing, 72-hour cat separation, drying, child-contact and swimming restrictions still add household burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats. Keep treated dogs away from cats for 72 hours and until dry; wash an exposed cat with shampoo or soap and seek veterinary care immediately.
  • Do not use below 2 weeks of age, on extensive skin lesions or with hypersensitivity to permethrin or excipients.
  • Below 2 kg use only after veterinary benefit-risk assessment; consult before use in sick or debilitated dogs.
  • Do not combine with other pyrethroid, organophosphate or carbamate insecticides.
  • Avoid skin, eye and mouth exposure; keep children from handling the dog until dry and do not share a bed immediately after treatment.
  • Permethrin is hazardous to aquatic organisms; keep treated dogs out of surface water for two days.
  • Monitor lethargy, local skin reaction, salivation, vomiting, diarrhoea, agitation, ataxia, tremor, seizure or paresis; bathe and seek care if significant signs occur.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Permethrin1430 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer (register)
QUIMICA DE MUNGUÍA. S.A. (QUIMUNSA), Spain
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1747, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: დიქსი პერმეტრინი 1430 მგ დასაწვეთებელი ხსნარი ძაღლებისთვის
№ 138-11
Verified on: 20 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
1 pipette
Apply one complete 2 ml pipette to intact skin, divided equally between two sites from the shoulder blades to the tail base, for a dog weighing 15-30 kg. Flea and tick protection lasts up to 4 weeks; mosquito and sandfly durations are label-specific. NEVER USE IN CATS: permethrin is extremely toxic and may be fatal. Keep treated dogs away from cats for 72 hours and until dry; after cat exposure, wash with shampoo or soap and seek a veterinarian immediately. Do not use under 2 weeks or on extensive skin lesions. Avoid eyes, mouth and licking. Do not combine with other pyrethroid, organophosphate or carbamate insecticides. Keep out of waterways; do not let treated dogs swim in surface water for 2 days.
Dog 14.99–30 kg On the skin single application; repeat only on veterinary advice, no sooner than 7 days
AEMPS SPC 2025
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
DIXIE Permethrin 1430 mg spot-on solution for dogs - Summary of Product Characteristics
Spanish Agency of Medicines and Medical Devices, CIMA-Vet, 2025
Active substance doses, with sources
Active substance Permethrin
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
50 mg/kg Dog Maintenance On the skin according to the epidemiological situation
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Advantix 40 mg + 200 mg spot-on solution for dogs (<= 4 kg) - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2026
60 mg/kg Dog Maintenance On the skin not more often than once every 4 weeks
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Effitix 26.8 mg/240 mg spot-on solution for very small dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025

Known Contraindications

  • Critical
    Do not use in cases of hypersensitivity to the active substances, or to any of the excipients.
    Sources: VMD SPC · VMD
  • Warning (Dog)
    In the absence of available data the veterinary medicinal product should not be used on puppies of less than 7 weeks of age or 1.5 kg of weight. The safety of the product has not been established in dogs younger than 12 weeks of age or in dogs weighing less than 1.5 kg.
    Sources: VMD SPC · VMD
  • Caution (Dog)
    Can be used during pregnancy and lactation. The safety of the veterinary medicinal product has not been established in dogs during pregnancy, lactation or in animals intended for breeding. Laboratory studies in rabbits and rats with the excipient N-methyl pyrrolidone have shown evidence of foetotoxic effects. Use only according to the benefit-risk assessment by the responsible veterinarian. The safety of the veterinary medicinal product has not been established during pregnancy and lactation in bitches. Use in pregnancy and lactation only in accordance with professional veterinary advice and a benefit/risk assessment.
    Sources: VMD SPC · VMD
  • Caution (Dog)
    Can be used during pregnancy and lactation. Use only according to the benefit-risk assessment by the responsible veterinarian.
    Sources: VMD SPC · VMD

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.